from [2003] [2004] [2005] [2006] . Patients with oropharyngeal SCC (OPSCC) (nϭ115) treated between 2003 -2006 had improved DFS compared to OPSCC patients treated between 1997 -2002 . Subgroup analysis revealed no difference in DFS between patients with laryngeal SCC (nϭ31) from the same date ranges. CONCLUSION: Planned neck dissections may not be necessary following treatment with CCR for all patients with advanced (N2 or N3) cervical nodal metastatic disease. Patients with OPSCC treated between 2003 and 2006 had improved DFS compared to earlier dates. Improved survival in OPSCC, in more recent years, may relate to better treatment strategies or represent increased incidence of HPV-associated cancers with associated improvement in response rates amongst tumors caused by HPV.
PTPN13 Expression Correlates with Survival in HPV؉ HNSCC
George Harris, MD (presenter); Aaron Bossler, MD, PhD OBJECTIVE: The human papillomavirus (HPV) oncogene E6 has been shown to perform multiple functions (p53 degradation, telomerase activation, etc.) that play a role in oncogenic transformation. Beyond known E6 functions, a recently defined mechanism that allows cellular invasion requires the E6 PDZ binding motif (PDZBM) to induce loss of a protein tyrosine phosphatase (PTPN13) in a PDZBM-dependent manner. However, variations in PTPN13 expression within HPVpositive and -negative tumors can be identified. Our first objective was to quantify this variation among a cohort of oropharyngeal squamous cell carcinomas (OPSCC). The second objective was to correlate survival differences within the cohort. METHOD: Retrospective review of patients in the UIHC Oncology Registry with oropharyngeal HNSCC who were diagnosed in 1995 and who had tissue samples available for analysis (Nϭ21). HPV typing and activity was done by RT-PCR and DNA was extracted from paraffin-embedded blocks, followed by sequencing and the use of genetic databases for typing. Immunohistochemistry was used to evaluate the status of PTPN13. Direct comparisons and multivariant analysis examined the correlation of HPV status, PTPN13 status, and survival over greater than 10 years. RESULTS: HPV was identified and activity was confirmed by increased p16 immunochemical staining, an accepted marker of HPV activity. Immunohistochemistry demonstrated variable expression of PTPN13 in HPV-positive tumors. Patients with HPV-positive squamous cell carcinoma and decreased PTPN13 had a significantly increased observed survival (pϭ0.016) versus HPV-positive patients with elevated or unchanged PTPN13. An average increase in survival of about 30 months was seen for those patients who had decreased expression of PTPN13 within the tumor.
CONCLUSION:
These findings suggest that patients who develop HNSCC associated with HPV without the additional genetic hit associated with abnormal PTPN13 have improved survival, possibly related to less genetic changes. Analyzing PTPN13 status in HPV-positive HNSCC may identify those patients that will have better survival or, conversely, those patients which may require additional treatment.
Race as a Social Construct in Head and Neck Cancer Outcomes
Maria Worsham, PhD, FACMG (presenter); George Divine, PhD; Rick Kittles, PhD OBJECTIVE: Racial differences in diagnosis and prognosis outcomes in head and neck squamous cancer (HNSCC) are usually based on self-reported race, which does not allow for the critical scientific investigation of biological factors. Here we used ancestry informative markers (AIMs) to estimate individual ancestry (IA) to test if West African genetic ancestry contributed to stage and survival outcomes in a primary HNSCC cohort. METHOD: 109 AIMS for West Africa and European genetic background were assayed in 358 patients with HNSCC who self-reported race as Caucasian American (CA), African American (AA), or other. Associations with stage at diagnosis (late vs early stage) and overall survival (time to death) were analyzed using logistic regression and Cox regression modeling, respectively, accounting for demographic, histopathology, and clinical risk variables, including smoking and alcohol. A subgroup analysis for diagnosis and survival was performed for self-reported AAs with West African IA of 15% or more. RESULTS: There were significant associations between stage and self-reported race [pϭ0.036] and with cancer site [pϭ0.001]. For prognosis, there were significant associations between stage, age group, and cancer site, but self-reported race was not associated with overall survival (pϭ0.384). There was no association with degree of West African ancestry and stage or survival. CONCLUSION: In this study, only self-reported race was associated with stage. Stratification within the AA group by IA showed no correlation with stage or survival, suggesting that race as a risk factor for head and neck cancer outcomes are likely due to social determinants rather than biological differences.
Racial Disparity in HPV Prevalence in SCCHN Patients
Kristen Angster, BS (presenter); Lisa Schumaker, BS; Shital Patel, MD (MBBS); Duane Sewell, MD; Kevin Cullen, MD OBJECTIVE: 1) Investigate the prevalence of HPV positive oropharyngeal cancer in black vs white patients; 2) Understand the impact this disparity has on overall survival.
METHOD:
The TAX 324 trial showed that the proportion of HPV positive oropharyngeal tumors was nine times higher in white versus black patients. HPV positive tumors exhibited a dramatically improved overall survival leading to an overall improved survival rate in white versus black patients. To confirm the racial disparity observed in Tax324 we performed a retrospective analysis in a larger sample size of 480 patients with oropharyngeal cancer treated at a single institution between 1995 and 2007. HPV-16 status was evaluated by PCR of DNA extracted from pretreatment biopsies embedded in paraffin. RESULTS: Among the 480 patients, detailed clinical information is available for 288 patients, and HPV status is known for 155 patients. 56% of patients are white and 44% are black. 84% of the patients are male. Median age is 56. The majority of patients (64%) are stage IV. Of patients with informative HPV samples, 40/95 (42%) of white patients are HPV positive while only 7 of 60 black patients (12%) are HPV positive (pϽ0.0001). CONCLUSION: This independent data set confirms the Tax324 trial observation that the prevalence of HPV positive oropharyngeal cancers is much lower in blacks than in whites. Together with the markedly favorable prognosis of HPV positive compared to HPV negative patients, this difference contributes significantly to overall racial survival disparities in oropharyngeal cancer.
Responsiveness of Osteosarcoma to Induction Chemotherapy
Alpha Tsui, MBBS, FRCPA (presenter); Claire Iseli, MBBS, MS; David Wiesenfeld, MD, FRACDS; Anthony Guiney, MBBS, FRACS; Tim Iseli, MBBS OBJECTIVE: To assess the histologic effects of induction chemotherapy in patients with osteosarcoma of the head and neck, treated surgically at Royal Melbourne Hospital. METHOD: Retrospective chart review of 23 head and neck osteosarcomas treated between January 1992 and January 2010. Induction chemotherapy was used in 13 cases and surgery alone in 10. Histology slides were reviewed by a senior pathologist. RESULTS: 13 patients underwent induction chemotherapy for 2 cycles followed by surgical resection then consolidation chemotherapy for 4 cycles. Free flap reconstruction was performed in 20 cases, 11 following induction chemotherapy. Nine patients completed the full course of chemotherapy, with 4 stopping due to side effects. Histology showed good response (Ͼ50% kill) in 1 patient, partial response (10-50% cell kill) in 2 patients and no response in 10 patients (77%). Surgical delay occurred in 4 patients (31%) due to bone marrow toxicity. Minor complications occurred in 5 patients and major in 1 patient in the chemotherapy group, similar to the surgery alone group. Local recurrence and survival was similar in the chemotherapy and surgery. CONCLUSION: Induction chemotherapy does not seem to have a significant effect in tumor reduction when used pre operatively. We believe that surgical resection of the tumor and reconstruction with post operative chemotherapy is a better management option for these patients as it avoids delays and the unavoidable increase of tumor size.
Results of a Community Based Head and Neck Cancer Screening
Justin Wise, PhD (presenter)
OBJECTIVE:
The overall aim of this study was to examine the usefulness of a large scale head and neck cancer screening for reducing smoking behavior in an at-risk population (i.e., NASCAR fans). METHOD: Participants were recruited from NASCAR fans touring the midway before entry into the race venue. Individuals who agreed to undergo a free head and neck cancer screening were given an initial survey and were directed to a tent to undergo a head and neck screening by a healthcare professional who specialized in the detection of head and neck cancer. At six months post-screening, those individuals that reported current use of tobacco were contacted by phone and given a phone interview survey. RESULTS: A 2 (screening findings) X 2 (time point) repeated measures ANOVA indicated that overall, participants reported smoking significantly less cigarettes per day (M ϭ 13.78) at the six month follow up compared to the number of cigarettes (M ϭ 19.43) smoked at the baseline time point, F (1, 72) ϭ 31.86, p Ͻ .001, ?2 ϭ .31. Forty-four (59%) participants reported reducing the number of cigarettes they smoked per day and 11 participants reported quitting smoking. CONCLUSION: Results from this study indicate that a largescale community-based head and neck cancer screening can effectively be implemented in nonmedical venues. Findings from this study targeting education to reduce smoking behavior indicated that 6 months post screening, participants reported smoking significantly less cigarettes per day. This was true in both those with concerning signs or symptoms for head and neck cancer and those with normal exams. 
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